Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Colorectal Neoplasms 7Colonic Neoplasms 6Recurrence 4Prostatic Neoplasms 4Neoplasms 4Polycythemia Vera 3Venous Thromboembolism 2Thrombocythemia, Essential 2Rectal Neoplasms 2Myocardial Infarction 2Esophageal Neoplasms 2Cardiovascular Diseases 2Adenoma 2Vascular Diseases 1Thrombosis 1Thrombocytopenia 1Stomach Neoplasms 1Primary Myelofibrosis 1Precancerous Conditions 1Pathologic Processes 1Node Positive HER2 Negative Breast Cancer 1Neoplasms by Site 1Neoplasm Metastasis 1Myocardial Ischemia 1Myeloproliferative Disorders 1Multiple Myeloma 1Lynch syndrome I (site-specific colonic cancer) 1Lymphoma, Follicular 1Liver Cirrhosis 1Ischemic Stroke 1

Interventions

ruxolitinib 6Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Cytarabine 5fludarabine phosphate 4Whole-Body Irradiation 4Methotrexate 4Daunorubicin 4Thioguanine 3Tacrolimus 3Etoposide 3Early Intervention, Educational 3Cyclophosphamide 3ponatinib 2parsaclisib 2nilotinib 2merphos 2luspatercept 2fludarabine 2fedratinib 2anagrelide 2Tretinoin 2Therapeutics 2Psychiatric Rehabilitation 2Mitoxantrone 2Filgrastim 2Cyclosporins 2Cyclosporine 2Busulfan 2Asparaginase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Myeloproliferative Disorders × Aspirin × Clear all
NCT06002490 2024-11-08

A Study to Evaluate P1101 in Japanese PV Patients

PharmaEssentia Japan K.K.

Phase 3 Completed
21 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡